Value of Post-NAC CT-based Node-RADS score for Predicting residual lymph node metastasis and survival outcome of locally advanced gastric cancer.
1/5 보강
PICO 자동 추출 (휴리스틱, conf 3/4)
유사 논문P · Population 대상 환자/모집단
118 patients with LAGC underwent neoadjuvant chemotherapy (NAC) and gastrectomy from April 2015 to June 2020.
I · Intervention 중재 / 시술
neoadjuvant chemotherapy (NAC) and gastrectomy from April 2015 to June 2020
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
[CONCLUSION] The post-NAC Node-RADS score provides accurate prediction of regional LNM and shows promising prognostic value for LAGC patients. Post-NAC Node-RADS related predictive models show potential in early identification of high-risk LAGC patients with residual lymph nodes or poor prognosis after NAC.
[OBJECTIVES] The Node Reporting and Data System (Node-RADS) provides structured and effective evaluation for lymph nodes in malignancies.
- p-value p < 0.001
- p-value p < 0.05
- 95% CI 0.765-0.921
- Sensitivity 78.9%
APA
Sun Y, Xiao H, et al. (2025). Value of Post-NAC CT-based Node-RADS score for Predicting residual lymph node metastasis and survival outcome of locally advanced gastric cancer.. Abdominal radiology (New York), 50(9), 3936-3949. https://doi.org/10.1007/s00261-025-04843-w
MLA
Sun Y, et al.. "Value of Post-NAC CT-based Node-RADS score for Predicting residual lymph node metastasis and survival outcome of locally advanced gastric cancer.." Abdominal radiology (New York), vol. 50, no. 9, 2025, pp. 3936-3949.
PMID
39948223 ↗
Abstract 한글 요약
[OBJECTIVES] The Node Reporting and Data System (Node-RADS) provides structured and effective evaluation for lymph nodes in malignancies. This study aims to investigate its value in predicting residual lymph node metastasis (LNM) and survival outcome of locally advanced gastric cancer (LAGC).
[MATERIALS AND METHODS] This retrospective study included 118 patients with LAGC underwent neoadjuvant chemotherapy (NAC) and gastrectomy from April 2015 to June 2020. The diagnostic performance of the post-NAC CT-based Node-RADS score for regional LNM, both at the patient level and at the perigastric/extragastric subgroup level, was estimated using area under receiver operating characteristic curve (AUC) and Youden's index. Kaplan-Meier curve was employed for prognostic analyses between high/low Node-RADS score group. A predictive Node-RADS (NR) model for LNM was developed using logistic regression analyses and a prognostic NR model for overall survival (OS) was developed using Cox regression analyses.
[RESULTS] In the prediction of LNM, the Node-RADS score exhibited an AUC of 0.843 (95%CI: 0.765-0.921) at patient level, 0.838 (95%CI: 0.757-0.918) in perigastric subgroup and 0.813 (95%CI: 0.724-0.901) in extragastric subgroup, surpassing LN short-axis criteria (AUC:0.664 [95%CI: 0.584-0.743], p < 0.001). The AUC of the NR predictive model for LNM increased to 0.870 (95%CI: 0.795-0.945), with 88.7% sensitivity and 78.9% specificity. The Node-RADS score was significantly correlated with post-NAC pathological status, and served as an independent indicator for OS (all p < 0.05).The NR prognostic model exhibited a Harrell's consistency index (C-index) of 0.724 (95%CI: 0.663-0.785), with no significant difference from the pathological prognostic model (0.739 [95%CI: 0.677-0.801], p = 0.695).
[CONCLUSION] The post-NAC Node-RADS score provides accurate prediction of regional LNM and shows promising prognostic value for LAGC patients. Post-NAC Node-RADS related predictive models show potential in early identification of high-risk LAGC patients with residual lymph nodes or poor prognosis after NAC.
[MATERIALS AND METHODS] This retrospective study included 118 patients with LAGC underwent neoadjuvant chemotherapy (NAC) and gastrectomy from April 2015 to June 2020. The diagnostic performance of the post-NAC CT-based Node-RADS score for regional LNM, both at the patient level and at the perigastric/extragastric subgroup level, was estimated using area under receiver operating characteristic curve (AUC) and Youden's index. Kaplan-Meier curve was employed for prognostic analyses between high/low Node-RADS score group. A predictive Node-RADS (NR) model for LNM was developed using logistic regression analyses and a prognostic NR model for overall survival (OS) was developed using Cox regression analyses.
[RESULTS] In the prediction of LNM, the Node-RADS score exhibited an AUC of 0.843 (95%CI: 0.765-0.921) at patient level, 0.838 (95%CI: 0.757-0.918) in perigastric subgroup and 0.813 (95%CI: 0.724-0.901) in extragastric subgroup, surpassing LN short-axis criteria (AUC:0.664 [95%CI: 0.584-0.743], p < 0.001). The AUC of the NR predictive model for LNM increased to 0.870 (95%CI: 0.795-0.945), with 88.7% sensitivity and 78.9% specificity. The Node-RADS score was significantly correlated with post-NAC pathological status, and served as an independent indicator for OS (all p < 0.05).The NR prognostic model exhibited a Harrell's consistency index (C-index) of 0.724 (95%CI: 0.663-0.785), with no significant difference from the pathological prognostic model (0.739 [95%CI: 0.677-0.801], p = 0.695).
[CONCLUSION] The post-NAC Node-RADS score provides accurate prediction of regional LNM and shows promising prognostic value for LAGC patients. Post-NAC Node-RADS related predictive models show potential in early identification of high-risk LAGC patients with residual lymph nodes or poor prognosis after NAC.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- SP-1-activated LINC01016 overexpression promotes gastric cancer invasion and metastasis through inhibiting EIF4A3-mediated MMP9 mRNA decay.
- Construction of hollow double shell NiMn PBA nanozymes for sensitive sarcosine detection a cascade strategy.
- Polydopamine-modified cyclodextrin metal-organic framework for efficient BCL-2 siRNA delivery in lung cancer therapy.
- Nuclear phosphoinositide signaling in cell biology and disease.
- CircNF1 promotes gastric cancer metastasis by stabilizing HMGA2 mRNA through IGF2BP1 interaction.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.